All In Biotech

Drug Trial Radar · NCT02406014

Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

Last checked: Nov 20, 2026Latest source record: Feb 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 502 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

502

Actual

Start

Apr 2015

Primary completion

Jun 2016

Study completion Jun 2016

Sponsor

Lead sponsor
LEO PharmaIndustry
Sponsor type
Industry
First posted
Apr 1, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 4, multi-centre, randomized, two group, open label, active controlled, parallel group, 17 week trial.

Conditions

  • Actinic Keratosis (AK)

Interventions

  • Ingenol Mebutate Gel, 0.015%Drug

    Ingenol mebutate gel 0.015 % (Picato®) applied on the selected treatment area. Retreatment if the treatment field is not completely cleared of AKs.

  • Diclofenac sodium gel 3%Drug

    Diclofenac sodium gel 3% Solaraze® applied on the selected treatment area, twice daily for 90 days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete clearance of all AKsTime frame: 11 Months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Gemain, Weber & Craninic

    Schweinfurt, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.